Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftaroline vs ceftriaxone for community-acquired bacterial pneumonia (CABP) in adults
CTR20132681Phase 3Completed
- Sponsor
- Facta Farmaceutici
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ceftaroline fosamil in community acquired pneumonia (CAP), sponsored by Facta Farmaceutici. Started Apr 2014; status: completed.
02
Drugs
ceftaroline fosamil
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on CTR20132681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132681.